The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, all. Damian here with a look at…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, all. Damian here with a look at biotech’s early-year volatility, the debut of a new venture fund, and the perils of accepting reality.
What's Your Reaction?
